EVENTIDE ASSET MANAGEMENT LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:24 pm Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -4,529,997 (Position Closed) | Filing |
| 2024-02-14 12:18 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | EVENTIDE ASSET MANAGEMENT LLC | 4,529,997 8.300% | 1,379,997 (+43.81%) | Filing |
| 2023-02-14 1:32 pm Purchase | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | EVENTIDE ASSET MANAGEMENT LLC | 3,150,000 6.600% | 3,150,000 (New Position) | Filing |